Robuta

https://www.rcsb.org/structure/4I21 RCSB PDB - 4I21: Crystal structure of L858R + T790M EGFR kinase domain in complex with MIG6 peptide Crystal structure of L858R + T790M EGFR kinase domain in complex with MIG6 peptide https://www.spandidos-publications.com/10.3892/ol.2014.2321?text=fulltext Lung adenocarcinoma harboring L858R and T790M mutations in epidermal growth factor receptor, with... Oncology Letters is an international journal devoted to Experimental and Clinical Oncology. https://www.ncbi.nlm.nih.gov/Structure/pdb/7JXM 7JXM: EGFR kinase (T790M/V948R) in complex with osimertinib and EAI045 Epidermal growth factor receptor(2R)-2-(5-fluoro-2-hydroxyphenyl)-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)-N-(1,3-thiazol-2-yl)acetamideMAGNESIUM... egfrkinaset790m https://www.rcsb.org/structure/4WD5 RCSB PDB - 4WD5: Crystal structure of EGFR 696-1022 T790M in complex with QL-X138 Crystal structure of EGFR 696-1022 T790M in complex with QL-X138 https://www.semanticscholar.org/topic/EGFR-T790M-Inhibitor-PF-06747775/2727832 EGFR T790M Inhibitor PF-06747775 | Semantic Scholar An orally available inhibitor of the epidermal growth factor receptor (EGFR) mutant form T790M, with potential antineoplastic activity. EGFR T790M inhibitor... egfrt790minhibitorpfsemantic https://www.ncbi.nlm.nih.gov/Structure/pdb/4G5P 4G5P: Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 EPIDERMAL GROWTH FACTOR RECEPTORAfatinib, Bound... crystal structureegfr https://www.rcsb.org/structure/5HG9 RCSB PDB - 5HG9: EGFR (L858R, T790M, V948R) in complex with... EGFR (L858R, T790M, V948R) in complex with... rcsb pdbegfrt790mcomplex https://www.rcsb.org/structure/5EDQ RCSB PDB - 5EDQ: EGFR kinase (T790M/L858R) with inhibitor compound 15:... EGFR kinase (T790M/L858R) with inhibitor compound 15:... rcsb pdbegfrkinase https://www.ncbi.nlm.nih.gov/Structure/pdb/6JRX 6JRX: EGFR T790M/C797S in complex with compound 6i Epidermal growth factor... egfrt790mcomplexcompound6i https://www.nice.org.uk/guidance/ta653/informationforpublic Information for the public | Osimertinib for treating EGFR T790M mutation-positive advanced... Evidence-based recommendations on osimertinib (Tagrisso) for treating epidermal growth factor receptor (EGFR) T790M mutation-positive locally advanced or... information for the publicosimertinib